Registry-rich, real world oncology data

Drawing on clinical and registry partnerships from around the globe, TriNetX provides real-world data that combines histology, genomic variants, and other biomarkers with treatment, line change, and survival records, so your research can run deeper.

Staging, biomarkers, and more from CTR-curated registries 

Our partnerships with cancer registries around the world let us bring together a large and growing volume of primary site, histology, staging, and biomarker data.

Genomic data from hospitals and external laboratories

We source mutation and variant data from a cross section of genomic laboratories, for richer genetic profiles on a more diverse patient population.

Granular EHR and lab data, pre- and post-cancer

Detailed EHR data and lab results, from before diagnosis and after treatment, open new avenues of research into risks, treatment planning, and prognoses. 

Academic and community hospitals
from around the world

In our data, you’ll find the latest immunologic treatments for rare cancers, along with chemo line progressions for tumors that are all too common. 

The Global Oncology Network

The largest oncology network of its kind, powering your research with deep, longitudinal, and continuously refreshed data.

Real-time access to data on more than 8 million cancer patients in 9 countries

Inclusive of cancer registry, oncology EMR, and genomic data

Sourced globally from more than 100 academic and community hospitals

Define cohorts by primary site, histology, behavior, summary stage, TNM stage, and biomarker

Rapidly compare outcomes, including survival and time to next treatment, with our built-in analytics

Connect with the healthcare organizations treating patients of interest, for study site selection and targeted enrollment

Criteria for a prostate cancer cohort

New Opportunity | Site Selection

Are you interested in a Phase II trial in prostate cancer with Cellimmune Pharma?

Enrollment Period: 4 June 2022 – 4 Dec 2022
Total Patients at Your Organization: 123

Curated Oncology Datasets

Sourced from 17 centers of excellence in the United States, our oncology datasets combine structured EMR data, registry data, lab results, genomic variants, and mortality records from the Social Security Administration and private obituaries.

Our data models puts cancer in context. Unique identifiers for each patient, visit, and cancer diagnosis let you bring together the variables you need quickly.

Our datasets for breast and lung cancer are available to license now. We are building equally rich datasets for additional indications. Connect with us to learn about our roadmap.

Breast Cancer Dataset

Patients

Median age at diagnosis

Received hormone therapy as their first treatment course

Received immunotherapy as first course of therapy

Received beam radiation

Black or African-American patients

HER2+ patients

HR- patients

Lung Cancer Dataset

Patients

Median age at diagnosis

Received immunotherapy as their first treatment course

Received beam radiation

Non-small cell lung cancer patients

Small cell lung cancer patients

Current or prior smoker

Patients with EGFR mutation